Areas of Focus | Computational Drug Design - NFCR

Computational Drug Design

What is Computational Drug Design?

Drug design is the process of finding and testing new treatments based on biological targets. Computational drug design – often called computer-aided drug design – refers to the drug invention process that relies on computer modeling techniques.

Computational drug design has been significantly improved by advances in algorithms, large amounts of data and improved technology.

Support Breakthroughs in Computational Drug Design
Research and Beyond.

Researchers Working On Computational Drug Design

William L. Jorgensen, Ph.D.
Yale University
Ronald A. DePinho, M.D.
University of Texas MD Anderson Cancer Center
Ronald A. DePinho, M.D. University of Texas MD Anderson Cancer Center

Related Content